🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.980
+0.070 (2.41%)
Nov 18, 2026, 4:00 PM EST - Market closed

Galectin Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11.7117.7215.1225.6618.5939.65
Cash & Short-Term Investments
11.7117.7215.1225.6618.5939.65
Cash Growth
1.57%17.20%-41.08%38.02%-53.11%46.08%
Prepaid Expenses
1.21.712.132.041.952.17
Other Current Assets
-0.010.010.010.010.01
Total Current Assets
12.9119.4417.2527.7120.5541.82
Property, Plant & Equipment
0.10.02-0.050.09-
Other Long-Term Assets
-0.070.240.440.650.01
Total Assets
13.0119.5317.528.221.2941.83

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.53.255.666.433.891.81
Accrued Expenses
4.094.78.199.149.027.16
Current Portion of Long-Term Debt
38.75-21.49---
Current Portion of Leases
0.060.020.020.050.040.01
Other Current Liabilities
-0.060.060.060.060.07
Total Current Liabilities
46.418.0335.4115.6813.019.03
Long-Term Debt
-137.785.1672.7539.8329.05
Long-Term Leases
0.04--0.020.07-
Other Long-Term Liabilities
----0.571.13
Total Liabilities
46.45145.73120.5788.4453.4839.21

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.10.070.060.060.060.06
Additional Paid-In Capital
414.61304.07296.22291.85275.08271
Retained Earnings
-450.36-432.55-401.57-354.37-309.57-270.69
Total Common Equity
-35.64-128.41-105.29-62.46-34.430.37
Shareholders' Equity
-33.44-126.2-103.07-60.24-32.192.62
Total Liabilities & Equity
13.0119.5317.528.221.2941.83

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
38.85137.72106.6672.8139.9329.06
Net Cash (Debt)
-27.15-120-91.54-47.15-21.3410.59
Net Cash Growth
------60.90%
Net Cash Per Share
-0.38-1.88-1.47-0.78-0.360.18
Filing Date Shares Outstanding
100.8865.8363.1861.959.4459.36
Total Common Shares Outstanding
100.8865.263.1661.8559.4359.34
Working Capital
-33.511.41-18.1612.037.5432.79
Book Value Per Share
-0.35-1.97-1.67-1.01-0.580.01
Tangible Book Value
-35.64-128.41-105.29-62.46-34.430.37
Tangible Book Value Per Share
-0.35-1.97-1.67-1.01-0.580.01
Machinery
-0.070.070.070.070.07
Leasehold Improvements
-00000
SEC Filings: 10-K · 10-Q